Form 8-K
 
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM 8-K
 
Current Report Pursuant to Section 13 or 15(d)
of The Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): January 7, 2003
 
 
SYNBIOTICS CORPORATION
(Exact name of registrant as specified in its charter)
 
Commission file number 0-11303
 
California
  
95-3737816
(State or other jurisdiction of incorporation )
  
(I.R.S. Employer Identification No.)
 
11011 Via Frontera
San Diego, California
  
92127
(Address of principal executive offices)
  
(Zip Code)
 
Registrant’s telephone number, including area code: (858) 451-3771
 

 
Item 5.  Other Events
 
On January 7, 2003, we announced that Paul Richard Hays had joined Synbiotics Corporation as President and Chief Operating Officer, and that Mr. Hays had been appointed as a member of the Board of Directors.
 
Item 7.  Financial Statements, Pro Forma Financial Information and Exhibits
 
a)    Financial statements of businesses acquired
 
 
Not
 
applicable.
 
b)    Pro forma financial information
 
 
Not
 
applicable.
 
c)    Exhibits
 
 
99
 
Press release dated January 7, 2003 entitled “Synbiotics Announces New President and Chief Operating Officer”.
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
SYNBIOTICS CORPORATION
 
Date: January 15, 2003        
      
/s/ Keith A. Butler         
       
Keith A. Butler
Vice President - Finance and Chief Financial Officer

-1-

 
SECURITIES AND EXCHANGE COMMISSION
 
WASHINGTON, D.C.
 
EXHIBITS
 
TO
 
FORM 8-K
 
UNDER
 
SECURITIES EXCHANGE ACT OF 1934
 
SYNBIOTICS CORPORATION
 

 
EXHIBIT INDEX
 
Exhibit No.
   
Exhibit
99
   
Press release dated January 7, 2003 entitled “Synbiotics Announces New President and Chief Operating Officer”.